Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00151983
Status:
COMPLETED
Last Update Posted:
2015-07-09
First Post:
2005-09-07
Brief Title:
Safety Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD Previously Treated With Extended-Release Methylphenidate Therapy
Sponsor:
Noven Therapeutics
Organization:
Noven Therapeutics
Study Overview
Official Title:
A Prospective Open-Label Multi-Center Study Evaluating the Safety and Tolerability of Methylphenidate Transdermal System MTS in Children Aged 6-12 Previously Treated With Extended-Release Methylphenidate Product
Status:
COMPLETED
Status Verified Date:
2015-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the safety and tolerability of MTS while attempting to establish the appropriate starting dose for subjects previously on an existing long-acting methylphenidate product
Detailed Description:
Attention-DeficitHyperactivity Disorder ADHD is a psychiatric disorder characterized by 3 main symptoms inattention hyperactivity and impulsivity This study will assess the safety and tolerability of SPD485 while attempting to establish the appropriate starting dose for subjects previously on an existing long-acting methylphenidate product
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None